Molecular Insights on the Pathophysiology and Treatment of COVID-19

A review article discussing the pathogenesis and treatment of COVID-19 as of April 2020. Authored by Hussin A. Rothan of Georgia State University, it covers epidemiological data, cellular receptors, co-morbidity with cardio-metabolic disease, and potential treatments in clinical trials.

Use Cases

• Reviewing epidemiological trends of COVID-19 based on age and country-specific data mentioned in the description.
• Studying the role of cellular receptors and co-receptors in SARS-CoV-2 infection pathogenesis.
• Analyzing the co-morbidity of COVID-19 with cardio-metabolic diseases.
• Surveying potential treatment options evaluated in different stages of clinical trials.

Strengths

• Authored by a researcher from Georgia State University, providing academic credibility.
• Covers multiple aspects of COVID-19, including pathogenesis, epidemiology, and treatment pipelines.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred from the review text.
• The data is from a single review article and may not represent a primary dataset.
• Last update date is unknown; the epidemiological figures are from April 2020 and may be outdated.

Provenance

Source

paperswithcode

Collection Method

Authored review article.

Time Range

Context includes data as of April 11, 2020.

Geography

Global perspective mentioned.